GILLETTE.NS
Gillette India Limited [GILLETTE.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GILLETTE.NS Stock Summary
In the News
GILLETTE.NS Financial details
Company Rating
Strong Buy
Market Cap
208.84B
Income
3.91B
Revenue
35.46B
Book val./share
316.29
Cash/share
127.6
Dividend
85
Dividend %
1.24%
Employees
571
Optionable
No
Shortable
Yes
Earnings
29 May 2024
P/E
62.02
Forward P/E
-
PEG
17.63
P/S
6.56
P/B
-
P/C
50.49
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
120.03
EPS next Y
-
EPS next Q
-
EPS this Y
22.93%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
7.06%
Revenue last 5Y
5.88%
Revenue Q/Q
-4.21%
EPS Q/Q
12.13%
-
-
-
-
SMA20
0.2%
SMA50
-1.33%
SMA100
1.75%
Inst Own
-
Inst Trans
-
ROA
-
ROE
76%
ROC
-
Gross Margin
66%
Oper. Margin
14%
Profit Margin
10%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4222.55-7335.65
52W High
-12.16%
52W Low
+52.6%
RSI
45
Rel Volume
0.44
Avg Volume
15.81K
Volume
6.96K
Perf Week
-2.26%
Perf Month
-1.4%
Perf Quarter
5.17%
Perf Half Y
2.46%
-
-
-
-
Beta
0.207
-
-
Volatility
66.99%, 90.31%
Prev Close
0%
Price
6442.9
Change
-1.2%
GILLETTE.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
| Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 571.16 | 515.16 | 616.67 | 692.39 | 760.18 | |
| Net income per share | 77.62 | 70.64 | 95.25 | 88.79 | 109.15 | |
| Operating cash flow per share | 41.7 | 69.12 | 136 | 141.64 | 141.97 | |
| Free cash flow per share | 18.02 | 58.21 | 108.33 | 105.91 | 117.8 | |
| Cash per share | 42.95 | 70.81 | 50.45 | 88.79 | 143.14 | |
| Book value per share | 238.87 | 279.66 | 242.14 | 264.29 | 303.47 | |
| Tangible book value per share | 238.87 | 279.66 | 242.14 | 264.29 | 303.47 | |
| Share holders equity per share | 238.87 | 279.66 | 242.14 | 264.29 | 303.47 | |
| Interest debt per share | 2.41 | 1.73 | 1.66 | 3.27 | 2.4 | |
| Market cap | 243.96B | 162.36B | 184.86B | 162.86B | 165.37B | |
| Enterprise value | 242.56B | 160.05B | 183.22B | 159.97B | 160.83B | |
| P/E ratio | 96.46 | 70.54 | 59.56 | 56.29 | 46.49 | |
| Price to sales ratio | 13.11 | 9.67 | 9.2 | 7.22 | 6.68 | |
| POCF ratio | 179.53 | 72.09 | 41.71 | 35.29 | 35.75 | |
| PFCF ratio | 415.54 | 85.6 | 52.37 | 47.19 | 43.08 | |
| P/B Ratio | 31.34 | 17.82 | 23.43 | 18.91 | 16.72 | |
| PTB ratio | 31.34 | 17.82 | 23.43 | 18.91 | 16.72 | |
| EV to sales | 13.03 | 9.53 | 9.12 | 7.09 | 6.49 | |
| Enterprise value over EBITDA | 60.33 | 42.57 | 36.27 | 31.57 | 28.65 | |
| EV to operating cash flow | 178.5 | 71.07 | 41.34 | 34.66 | 34.77 | |
| EV to free cash flow | 413.16 | 84.39 | 51.9 | 46.35 | 41.9 | |
| Earnings yield | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | |
| Free cash flow yield | 0 | 0.01 | 0.02 | 0.02 | 0.02 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | -0.35 | -0.61 | -0.33 | -0.57 | -0.81 | |
| Current ratio | 1.69 | 2.02 | 1.46 | 1.43 | 1.53 | |
| Interest coverage | 45.15 | 59.73 | 85.26 | 41.63 | 61.86 | |
| Income quality | 0.4 | 0.72 | 1.03 | 1.12 | 0.98 | |
| Dividend Yield | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | |
| Payout ratio | 0.54 | 0.35 | 1.39 | 0.78 | 0.65 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | -0.02 | -0.02 | -0.02 | 0 | 0.08 | |
| Capex to operating cash flow | -0.57 | -0.16 | -0.2 | -0.25 | -0.17 | |
| Capex to revenue | -0.04 | -0.02 | -0.04 | -0.05 | -0.03 | |
| Capex to depreciation | -1.62 | -0.7 | -1.57 | -1.7 | -0.98 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 645.88 | 666.7 | 720.38 | 726.64 | 863.31 | |
| ROIC | 0.34 | 0.26 | 0.41 | 0.36 | 0.37 | |
| Return on tangible assets | 0.2 | 0.17 | 0.22 | 0.18 | 0.2 | |
| Graham Net | -6.69 | 27.96 | -30.83 | -22.04 | -3.84 | |
| Working capital | 2.45B | 3.86B | 2.42B | 2.89B | 4.34B | |
| Tangible asset value | 8.04B | 9.42B | 8.17B | 8.61B | 8.27B | |
| Net current asset value | 1.66B | 3.24B | 1.63B | 2.05B | 3.23B | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 1.02B | 2.08B | 2.11B | 2.38B | 2.94B | |
| Average payables | 3.05B | 2.84B | 3.48B | 4.77B | 6.12B | |
| Average inventory | 2.17B | 2.59B | 3.25B | 3.7B | 3.93B | |
| Days sales outstanding | 39.97 | 46.03 | 38.29 | 42.98 | 47.58 | |
| Days payables outstanding | 120.94 | 139.43 | 162.32 | 183.67 | 208.94 | |
| Days of inventory on hand | 100.65 | 137.93 | 145.7 | 125.93 | 126.68 | |
| Receivables turnover | 9.13 | 7.93 | 9.53 | 8.49 | 7.67 | |
| Payables turnover | 3.02 | 2.62 | 2.25 | 1.99 | 1.75 | |
| Inventory turnover | 3.63 | 2.65 | 2.51 | 2.9 | 2.88 | |
| ROE | 0.32 | 0.25 | 0.39 | 0.34 | 0.36 | |
| Capex per share | -23.69 | -10.91 | -27.67 | -35.72 | -24.16 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q2
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 189.85 | 189.98 | 496.99 | 204.86 | 196.24 | |
| Net income per share | 22.85 | 31.52 | 28.16 | 28.45 | 31.9 | |
| Operating cash flow per share | 11.78 | 13.4 | 17.17 | 12.33 | 12.71 | |
| Free cash flow per share | 11.78 | 13.4 | 17.17 | 12.33 | 12.71 | |
| Cash per share | 102.53 | 101.52 | 143.14 | 139.81 | 127.6 | |
| Book value per share | 278.07 | 278.07 | 303.47 | 303.47 | 316.29 | |
| Tangible book value per share | 278.07 | 0 | 303.47 | 0 | 316.29 | |
| Share holders equity per share | 278.07 | 278.07 | 303.47 | 303.47 | 316.29 | |
| Interest debt per share | 1.06 | 0.24 | 0.99 | 0.04 | 1.01 | |
| Market cap | 164.01B | 140.64B | 165.37B | 199.64B | 211B | |
| Enterprise value | 160.72B | 143.95B | 160.83B | 204.19B | 206.94B | |
| P/E ratio | 55.07 | 34.24 | 45.06 | 53.85 | 50.74 | |
| Price to sales ratio | 26.51 | 22.72 | 10.21 | 29.91 | 33 | |
| POCF ratio | 427.33 | 321.98 | 295.56 | 496.86 | 509.41 | |
| PFCF ratio | 427.33 | 321.98 | 295.56 | 496.86 | 509.41 | |
| P/B Ratio | 18.1 | 15.52 | 16.72 | 20.19 | 20.47 | |
| PTB ratio | 18.1 | 15.52 | 16.72 | 20.19 | 20.47 | |
| EV to sales | 25.98 | 23.25 | 9.93 | 30.59 | 32.36 | |
| Enterprise value over EBITDA | 124.62 | 98.95 | 108.35 | 140.46 | 126.95 | |
| EV to operating cash flow | 418.76 | 329.55 | 287.46 | 508.2 | 499.6 | |
| EV to free cash flow | 418.76 | 329.55 | 287.46 | 508.2 | 499.6 | |
| Earnings yield | 0 | 0.01 | 0.01 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | -2.55 | 2.27 | -3.05 | 3.13 | -2.49 | |
| Current ratio | 1.44 | 0 | 1.53 | 0 | 1.7 | |
| Interest coverage | 32.77 | 160.57 | 40.13 | 963.77 | 43.78 | |
| Income quality | 0.52 | 0.43 | 0.61 | 0.43 | 0.4 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0.08 | 0 | 0.09 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0.01 | 0 | 0 | |
| Graham number | 378.09 | 444.06 | 438.47 | 440.71 | 476.47 | |
| ROIC | 0.08 | 0.11 | 0.1 | 0.09 | 0.1 | |
| Return on tangible assets | 0.04 | 0 | 0.05 | 0 | 0.06 | |
| Graham Net | -21.52 | 101.52 | -3.84 | 139.81 | 10.71 | |
| Working capital | 3.19B | 3.31B | 4.34B | 4.56B | 4.71B | |
| Tangible asset value | 9.06B | 0 | 8.27B | 0 | 8.73B | |
| Net current asset value | 2.28B | 3.31B | 3.23B | 4.56B | 3.63B | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 1.45B | 1.45B | 1.61B | 1.61B | 1.18B | |
| Average payables | 3.1B | 3.1B | 3.4B | 3.4B | 2.89B | |
| Average inventory | 2.04B | 2.04B | 2.06B | 2.06B | 2.22B | |
| Days sales outstanding | 42.16 | 0 | 17.95 | 0 | 33.28 | |
| Days payables outstanding | 188.27 | 0 | 192.82 | 0 | 194.26 | |
| Days of inventory on hand | 123.75 | 0 | 116.91 | 0 | 149.22 | |
| Receivables turnover | 2.13 | 0 | 5.02 | 0 | 2.7 | |
| Payables turnover | 0.48 | 0 | 0.47 | 0 | 0.46 | |
| Inventory turnover | 0.73 | 0 | 0.77 | 0 | 0.6 | |
| ROE | 0.08 | 0.11 | 0.09 | 0.09 | 0.1 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
GILLETTE.NS Frequently Asked Questions
What is Gillette India Limited stock symbol ?
Gillette India Limited is a IN stock and trading under the symbol GILLETTE.NS
What is Gillette India Limited stock quote today ?
Gillette India Limited stock price is $6442.9 today.
Is Gillette India Limited stock public?
Yes, Gillette India Limited is a publicly traded company.
Company Profile
- Volume Average 15.81K
- Market Capitalization 208.84B
- Employee 571
- CEO Mr. Lalgudi Viswanathan Vaidyanathan
- Headquarters Mumbai,IN
- IPO Date 2002-07-01
-
Website
https://www.gillette.co.in 
Gillette India Limited manufactures and sells grooming and oral care products in India and internationally. The company offers shaving system and cartridges, blades, toiletries, razors, and components; and toothbrushes and oral care products. It also provides female grooming products under the Gillette Venus name; and body shaving and trimming, skin care, and aftershave products. The company sells its products primarily under the Gillette and Oral-B brands. It markets and sells its products through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, and high frequency stores. Gillette India Limited was incorporated in 1984 and is based in Mumbai, India.
